Evidence map›Paper›PMID 37623213›Full record

ArticleCurrent issues in molecular biology2023

ΔNp63 Regulates Radioresistance in Human Head and Neck Squamous Carcinoma Cells.

Kota Sato, Hironori Yoshino, Yoshiaki Sato, Manabu Nakano, Eichi Tsuruga

Open access · goldAbstract read
In one paragraph

Article in Current issues in molecular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kota SatoDepartment of Radiation Science, Graduate School of Health Sciences, Hirosaki University, Hirosaki 036-8564, Aomori, Japan.
Hironori YoshinoDepartment of Radiation Science, Graduate School of Health Sciences, Hirosaki University, Hirosaki 036-8564, Aomori, Japan.ORCID 0000-0003-2705-9929
Yoshiaki SatoDepartment of Radiation Science, Graduate School of Health Sciences, Hirosaki University, Hirosaki 036-8564, Aomori, Japan.ORCID 0000-0003-3375-5189
Manabu NakanoDepartment of Bioscience and Laboratory Medicine, Hirosaki University Graduate School of Health Sciences, Hirosaki 036-8564, Aomori, Japan.
Eichi TsurugaDepartment of Radiation Science, Graduate School of Health Sciences, Hirosaki University, Hirosaki 036-8564, Aomori, Japan.
Hirosaki University · JP

Funding

Interdisciplinary Collaborative Research Grant for Young Scientists, Hirosaki University. N/A
6 · The paper itself

Abstract

Radiation therapy is commonly used to treat head and neck squamous cell carcinoma (HNSCC); however, recurrence results from the development of radioresistant cancer cells. Therefore, it is necessary to identify the underlying mechanisms of radioresistance in HNSCC. Previously, we showed that the inhibition of karyopherin-β1 (KPNB1), a factor in the nuclear transport system, enhances radiation-induced cytotoxicity, specifically in HNSCC cells, and decreases the localization of SCC-specific transcription factor ΔNp63. This suggests that ΔNp63 may be a KPNB1-carrying nucleoprotein that regulates radioresistance in HNSCC. Here, we determined whether ΔNp63 is involved in the radioresistance of HNSCC cells. Cell survival was measured by a colony formation assay. Apoptosis was assessed by annexin V staining and cleaved caspase-3 expression. The results indicate that ΔNp63 knockdown decreased the survival of irradiated HNSCC cells, increased radiation-induced annexin V

Indexed as

head and neck squamous cell carcinomaionizing radiationkaryopherin-αkaryopherin-β1radiation-induced apoptosisradioresistanceΔNp63

Identifiers

PMID37623213
PMCPMC10453785
OpenAlexW4385370619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.